There is currently no ideal radiotracer for imaging protein synthesis rate (PSR) by positron emission tomography (PET). Existing fluorine-18 labelled amino acid-based radiotracers predominantly visualize amino acid transporter processes, and in many cases they are not incorporated into nascent proteins at all. Others are radiolabelled with the short half-life positron emitter carbon-11 which is rather impractical for many PET centers. Based on the puromycin (6) structural manifold, a series of 10 novel derivatives of 6 was prepared via Williamson ether synthesis from a common intermediate. A bioluminescence assay was employed to study their inhibitory action on protein synthesis which identified fluoroethyl analogue (7b) as a lead compound. The fluorine-18 analogue was prepared via nucleophilic substitution of the corresponding tosylate precursor in modest radiochemical yield 2±0.6% and excellent radiochemical purity (>99%) and showed complete stability over 3 h at ambient temperature.
the metal chelate, and carbon-11 radiolabelled 6 is limited by the short physical half-life of the radionuclide. We hypothesized that a fluorinated analogue of 6 would be a preferable radiotracer for PET imaging, as well as incorporating a more widely available radioisotope. The literature precedent demonstrates that derivatives of 6 modified at the phenyl ring retain the inhibitory activity of the parent, 13, 16, 19 which prompted us to investigate the effect of introduction of a fluorine atom into the scaffold of 6 by varying functional groups at the phenol as point of modification (7b-k, Figure 2 ). We also considered potential routes for facile introduction of fluorine-18 in this position using a nucleophilic approach. Herein, we report the synthesis of several derivatives of 6, their ability to inhibit PS, as well as the radiolabelling of the most prominent derivative as a potential PET radiotracer. Conversion to products with some electrophiles using the Williamson method was sluggish, likely because of the structural complexity of phenol 12. In support of this theory, the reactivity of 10 and 12 with fluoroethyl electrophiles was compared (Table 1) . Using mesylate as a leaving group in reaction with 12, conversion of 16% was observed by NMR after 25 h (entry 1) due to the significant amount of by-products formed. Reaction of 12 with 2-fluoroethyl tosylate gave only trace amount of product (entry 2) whereas heating the reaction mixture to 70
°C increased the yield of 13b to a modest 11% after 2 h and further to 44% when mixture was heated over 17 h (entries 3 and 4). On the other hand, reaction of 10 with 2-fluoroethyl tosylate proceeded with 37% NMR conversion (entry 6) at ambient temperature. Further improvement as a reference to establish conditions for deprotection of both the TBS and Boc groups without epimerization (Scheme 2). Alkyne 13f was therefore treated with TBAF·THF resulting in deprotection of both primary and secondary TBS groups in 17f. TFA was employed for the removal of the Boc protecting group and 7f was afforded in 34% yield. NMR analysis of 7f was in complete agreement with that previously reported (see Supporting Information). 16 An alternative two step deprotection was explored in which the Boc group was removed by TFA quantitatively first, and 18f was subsequently treated with TBAF·THF to yield 7f in 57% yield.
Interestingly, the primary TBS group in 13f was cleaved during the Boc removal with TFA;
however it was the secondary TBS which required application of TBAF.
Scheme 2. Two step deprotection of 13f via two routes, yielding desired 7f in structural agreement with the literature report. With the deprotection route established, the syntheses of other derivatives of 6 were completed in a one pot two step method. Intermediates 17 and 18 were not isolated; instead the second step was performed with the crude material to afford 7b-k (Scheme 3a). Treatment of 13a and 13k
with TBAF in a single step yielded Boc-protected analogues 17a and 17k (Scheme 3b). Using the synthetic method depicted in Schemes 1 and 2, derivative 7f was obtained in 20% yield over 4 steps from commercially available starting materials, which was an improvement to the previously reported preparation of 7f in a total of six steps, with 9% overall yield. 16 Yields obtained for the syntheses of various derivatives of 6 are shown in Table 2 . With the target molecules (6, 7b-k, 12, 13a, 17a, 17f, 17k) in hand, their PS inhibitory activity was assessed using a bioluminescent protein reporter system in bacteria. This technique has been previously established for the assessment of compounds that inhibit PS. 22 In this assay,
Gram positive bacteria Staphylococcus aureus 8325.4 were engineered to produce Gaussia Luciferase (GLuc), a 19 kD photoprotein. On addition of the GLuc substrate coelenterazine, a bioluminescent signal at 475 nm is produced proportional to the concentration of the GLuc protein, thus providing a sensitive method with which to detect differences in PS in bacterial culture. 23 The test compound or 6 dihydrochloride was independently applied to S. aureus culture, and the quantity of GLuc protein synthesized was measured by bioluminescence after 2.5 h. Cell number was estimated by optical density (OD) to normalize the response. The efficiency of the novel derivatives for PS inhibition compared with 6·2HCl (set at 100%) is displayed in Table 2 .
Comparable PS inhibitory activity of 7f to that of 6 was observed, as expected based on the published data (Table 2 , entries 6 and 1). 16 Only three other analogues showed comparable or better PS inhibitory effects at 50 µM concentration: 7b, 7e and 7g (entries 2, 5 and 7). At this concentration, non-fluorinated 7e proved the most potent PS inhibitor. Functionalization of 6 with either aromatic substituents (entries 3, 4 and 8) or [2 + 3] cycloaddition products, the "click" analogues (entries 9-11), resulted in reduction in inhibitory potency compared with 6.
Similarly, masking of the hydroxyl functional groups (entries 12 and 13), in addition to amine group (entries 14-16) confirmed importance of free hydroxyl and amine functionalities to maintain inhibitory activity. Figure 3 shows the concentration dependence of PS inhibitory activity of the novel derivatives. At all concentrations tested, 7b was the most potent of the fluorinated derivatives. At the lowest concentration tested (5 µM), 7b reduced protein production by 36% compared with 6, and proved to be a superior PS inhibitor to 7e (25% reduction compared with 6). With evidence to support the use of 7b (FEPURO, 5 µΜ 50 µΜ 500 µΜ radiolabelling precursor 24 (Scheme 4) was therefore envisioned as most appropriate.
Alongside synthesis of the radiolabelling precursor, we revisited the route to access 7b. Methyl ester 10 was reacted with 2-fluoroethyl tosylate to afford 15b in 42% (Table 1) (18-c-6, K 222 , TBAHCO 3 ) and precursor quantity (5-10 mg). Full details can be found in Table 3 . The optimal conversion of 22% was achieved using DMSO at 120 °C over 15 min as analysed by HPLC (entry 8). Heating the reaction to 130
°C resulted in only a slight increase in conversion to 24%, however five additional, radiolabelled species were observed by HPLC that eluted closely with [ used in the reaction resulted in a significant reduction in conversion to 12% (entry 11). 
